With a career that encompasses legal experience in both Munich and New York, Tim combines skills as a commercial mediator with expertise in biotechnology and medtech.

Today, Tim heads up Osborne Clarke’s German life sciences and healthcare group, advising national and international pharmaceutical, biotech and medtech companies clients in IP-related issues and regulatory matters.

He also provides legal guidance in the process of product development, including the negotiation of clinical trial, licensing and R&D agreements. And while technology plays an ever-growing role in the sector, Tim advises his clients in all legal aspects connected with the provision of digital healthcare offerings, such as digital applications, telemedicine and online pharmacies.

Alongside his advisory services, he represents his life sciences clients in litigation, primarily in patent infringement and competition law proceedings, also focusing on employee invention law.

As a trained commercial mediator, Tim supports his clients in mediation proceedings and is regularly called upon as a commercial mediator in IP-related disputes in the life sciences and healthcare sector.

He studied in Würzburg and obtained a doctorate in the area of intellectual property law before qualifying as a lawyer in 1996. Prior to joining Osborne Clarke in 2005, Tim held roles with an international law firm in Munich and New York.

Work

MA Ventures

Osborne Clarke advises MA Ventures on investment in Lykon, read more

Signiant

Osborne Clarke advises Signiant on acquisition of Lesspain Software, read more

Providence Strategic Growth

Osborne Clarke advises Providence Strategic Growth on investment in Hornetsecurity, read more

Handelsbatt

Osborne Clarke named "Law Firm of the Year Germany 2020", read more

Cathay Innovation

Osborne Clarke advises Cathay Innovation on MEDWING’s 28 million financing round, read more

Redalpine

Osborne Clarke advises Redalpine on EUR 6 million financing round in lengoo, read more

CeleraOne

Osborne Clarke advises CeleraOne on sale to Axel Springer, read more

Earlybird

Osborne Clarke advises Earlybird on €4m investment in Bitwala, read more

Goodix Technology

Osborne Clarke advised Goodix Technology on acquisition of Commsolid, read more

TomTec

Advised TomTec on its takeover by Philips, read more

Automotive software client

Helped a client expand their presence in the automotive software markets by navigating them through corporate transactions in Italy, Germany, Spain and the United Kingdom

PneumRx, Inc.

Advised this US medical device company on its entry to the German/European market by developing terms and conditions, purchase and rebate agreements with clinics, patient information brochures and patient consent forms

Uptake Medical Inc.

Advised this US medical device company that has developed a device for treating emphysema on its entry into the German market

Vakzine Projektmanagement GmbH

Advised in a number of international drug development agreements and regulatory matters

Allgeier

Advised Allgeier on acquisition of Ciber Germany, read more